Sec Form 13D Filing - MetLife Investment Management LLC filing for NEUBERGER BERMAN HIGH YID STRA (NHS) - 2023-09-20

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934

 

(Amendment No. 1)*

 

(Name of Issuer)

 

(TITLE OF CLASS OF SECURITIES)

 

(CUSIP Number)

 

MetLife Investment Management, LLC

One MetLife Way

 

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

(Date of Event Which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box ☐.

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

---

 

1	NAMES OF REPORTING PERSONS
	MetLife Investment Management, LLC 82-2405817
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP			(a)	☐
				(b)	☐
3	SEC USE ONLY
4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	WC
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)				☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION
	DE
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER
			0
		8	SHARED VOTING POWER
			0
		9	SOLE DISPOSITIVE POWER
			0
		10	SHARED DISPOSITIVE POWER
			0
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	0
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)				☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	0%
14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	IA

 

 

Item 1 of the Schedule 13D is hereby amended and supplemented as follows:

 

This Amendment No. 1 to Schedule 13D (“Amendment No. 1”) is being filed by the undersigned, pursuant to §240.13d-2(a), to amend and supplement the Schedule 13D filed with the U.S. Securities and Exchange Commission (the “SEC”) on October 27, 2020 (the “Initial Schedule 13D” and, together with this Amendment No. 1, the “Schedule 13D”), with respect to mandatory redeemable preferred shares, Series C (the “MRP Shares”) of Neuberger Berman High Yield Strategies Fund Inc. (the “Issuer”). The Issuer’s principal executive offices are located at 1290 Avenue of the Americas, New York, New York 10104. All capitalized terms not otherwise defined herein have the meanings ascribed to such terms in the Initial Schedule 13D.

 

 

Item 2 of the Schedule 13D is hereby restated in its entirety as follows:

 

Item 4 of the Schedule 13D is hereby amended and supplemented as follows:

 

On September 18, 2023, the MRP Shares were redeemed in full by the Issuer at their original purchase price of $12.50 per share, plus accrued and unpaid dividends.

 

 

Item 5 of the Schedule 13D is hereby amended and supplemented as follows:

 

(a) - (b) The responses of the Reporting Person to Rows (7) through (11) of the cover pages of this Amendment No. 1 are incorporated herein by reference.

 

(c) The response of the Reporting Person in Item 4 is incorporated herein by reference. Except as otherwise described in this Amendment No. 1, the Reporting Person had no transactions in the MRP Shares during the 60 days preceding the date of filing of this Amendment No. 1.

 

(d) The Reporting Person managed the MRP Shares on behalf of various clients.

 

(e) As of September 18, 2023, the Reporting Person ceased to beneficially own more than 5% of the MRP Shares outstanding.

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

 

The following sets forth the name and present principal occupation of each executive officer and director of MetLife Investment Management, LLC. The business address of each of the executive officers and directors of MetLife Investment Management, LLC is One MetLife Way, Whippany, New Jersey 07981.

---